Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study. | Front Neurosci | 2023 | 37021137 | PubTator, text mining | PubMed |
| Neural spiking for causal inference and learning. | PLoS Comput Biol | 2023 | 37014913 | PubTator, text mining | PubMed |
| Comparison of Genetic Profiles of Neonates in Intensive Care Units Conceived With or Without Assisted Reproductive Technology. | JAMA Netw Open | 2023 | 37014641 | PubTator, text mining | PubMed |
| Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment. | Front Neurosci | 2023 | 36998727 | PubTator, text mining | PubMed |
| AVPR2 is a potential prognostic biomarker and correlated with immune infiltration in head and neck squamous cell carcinoma. | BMC Med Genomics | 2023 | 36998036 | PubTator, text mining | PubMed |
| The Effects of SGLT2 Inhibitors on Liver Cirrhosis Patients with Refractory Ascites: A Literature Review. | J Clin Med | 2023 | 36983252 | PubTator, text mining | PubMed |
| Coelenterazine-Type Bioluminescence-Induced Optical Probes for Sensing and Controlling Biological Processes. | Int J Mol Sci | 2023 | 36982148 | PubTator, text mining | PubMed |
| Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry Disease. | Diagnostics (Basel) | 2023 | 36980460 | PubTator, text mining | PubMed |
| Establishing 20S Proteasome Genetic, Translational and Post-Translational Status from Precious Biological and Patient Samples with Top-Down MS. | Cells | 2023 | 36980185 | PubTator, text mining | PubMed |
| Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management. | Endocr Rev | 2023 | 36974717 | PubTator, text mining | PubMed |
| New insights into GPCR coupling and dimerisation from cryo-EM structures. | Curr Opin Struct Biol | 2023 | 36963163 | PubTator, text mining | PubMed |
| Apelin is altered in subjects with autosomal dominant polycystic kidney disease and preserved kidney function. | Nephrol Dial Transplant | 2023 | 36945109 | PubTator, text mining | PubMed |
| Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents. | BMC Psychiatry | 2023 | 36932364 | PubTator, text mining | PubMed |
| Early Initiation of Dapagliflozin during Hospitalization for Acute Heart Failure Is Associated with a Shorter Hospital Stay. | Intern Med | 2023 | 36927973 | PubTator, text mining | PubMed |
| Inactivation of Invs/Nphp2 in renal epithelial cells drives infantile nephronophthisis like phenotypes in mouse. | Elife | 2023 | 36920028 | PubTator, text mining | PubMed |
| Radical Pairing Interactions and Donor-Acceptor Interactions in Cyclobis(paraquat-p-phenylene) Inclusion Complexes. | Molecules | 2023 | 36903306 | PubTator, text mining | PubMed |
| Helicobacter pylori outer membrane vesicles induce astrocyte reactivity through nuclear factor-κappa B activation and cause neuronal damage in vivo in a murine model. | J Neuroinflammation | 2023 | 36895046 | PubTator, text mining | PubMed |
| The role of G protein-coupled receptor in neutrophil dysfunction during sepsis-induced acute respiratory distress syndrome. | Front Immunol | 2023 | 36891309 | PubTator, text mining | PubMed |
| Two-step structural changes in M3 muscarinic receptor activation rely on the coupled Gq protein cycle. | Nat Commun | 2023 | 36882424 | PubTator, text mining | PubMed |
| Metabolism-based approaches for autosomal dominant polycystic kidney disease. | Front Mol Biosci | 2023 | 36876046 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=17